Wockhardt Limited

Wockhardt Limited is a global pharmaceutical and biotechnology company engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical and biopharmaceutical products. Their product portfolio encompasses a diverse range of therapeutic areas including cardiovascular, central nervous system, gastroenterology, anti-infectives, respiratory, and oncology. The company operates across numerous countries, with a significant presence in both developed and emerging markets. Wockhardt's operations extend to the manufacturing of Active Pharmaceutical Ingredients (APIs), formulations, and biosimilars. The company is known for its integrated approach, controlling various stages of the pharmaceutical value chain, from raw material sourcing to product distribution. They have a strong focus on innovation and research, investing in the development of novel therapies and advanced drug delivery systems. Wockhardt also emphasizes compliance with stringent international quality and regulatory standards across its operations.